ID1 and prostate cancer: Inhibitor of DNA-binding-1 expression was high in two androgen-independent prostate cancer cell lines, DU145 and PC3, but its expression is undetectable in the androgen-dependent cell line LNCaP under serum-free conditions (Ling et al, 2003).